Navigation Links
Neuro Kinetics to Release VEST(TM) 6.7 Software at Audiology Conference
Date:3/26/2009

Software Upgrade Enhances Company's Lead in Data Quality, Gives Clinicians Power to Expand Evaluations & Improve Analysis

PITTSBURGH, March 26 /PRNewswire-FirstCall/ -- Neuro Kinetics, Inc. (NKI) (www.neuro-kinetics.com) , manufacturers of noninvasive medical evaluation equipment used worldwide for balance, vestibular and neurological disorder tests, said today that it will release version 6.7 of its proprietary VEST(TM) control and analysis software at the upcoming AudiologyNOW! 2009 -- the annual conference of the American Academy of Audiology to be held next month in Dallas.

NKI said that VEST 6.7 incorporates more than 70 new features and enhancements designed to enable clinicians to conduct a larger array of patient tests and generate more accurate data to improve diagnosis. The upgraded software also improves the functionality of NKI's evaluation equipment.

"We have made a significant commitment as a company to listen to our users and act on their recommendations and suggestions," said Howison Schroeder, NKI CEO and president. "We're excited to be rolling out the dramatically improved and robust software to our users around the world. With the better data quality now available, clinicians will be able to generate more accurate analysis and diagnosis."

The VEST software is used by audiologists, neurologists, neuro-otologists, ophthalmologists, otolaryngologists and other medical specialists to undertake patient evaluations and then analyze data generated through an array of motion, ocular motor and nystagmus tests. Based on National Instruments technology, VEST includes reporting features for reimbursable tests, built-in analytical tools and normative data for comparative analysis.

Among the highlights of VEST 6.7:

  • IMPROVED REAL-TIME ANALYSIS. VEST 6.7 now provides expanded normative data results in the analysis interface to help users more easily and efficiently interpret data.

  • ADDED ANALYSIS FLEXIBILITY. Users can now save analysis filter settings for every test when using the Analysis Manager utility and can revert to default settings when needed. Default settings can also now be redefined while analyzing data.

  • ENHANCED DATA COLLECTION. VEST 6.7 features an improved communication protocol that works in conjunction with the new I-Portal(R) software version 2.4. The new protocol makes more efficient use of hardware resources, allowing the system to capture and report even more robust eye data.

  • NEW REMOTE PEDAL CONTROL FUNCTIONALITY. VEST 6.7 introduces a new onscreen pedal guide, allowing the user to confirm pedal function when using NKI's I-Portal(R) VNG (Video Nystagmography) and I-Portal(R) VOG (Video-Oculography) systems. The onscreen guide can be moved throughout both monitor screens for optimal viewing and offers a large font that can be easily seen while performing more remote tests. The virtual pedals that appear on the guide are fully interactive and the user has the ability to enable or disable audio commands to help communicate pedal functionality. Users can now take advantage of the pedal controls during additional tests, including saccade, gaze, smooth pursuit, spontaneous, positional, positioning and caloric.

  • EXPANDED SACCADE TESTING AND ANALYSIS. The upgraded VEST software enables expanded saccade testing, allowing up to 100 saccades to be defined in the testing protocol. Saccade analysis has been enhanced to allow for evaluation of corrective saccades, which are clearly identified for the user and can be easily assessed via the enhanced data plotting windows.

Other benefits include improved user controls over video recordings for VNG and VOG users along with new binocular VOG recording compatibility.

For more information about VEST 6.7 or any other NKI product or service, please call the company in the U.S. +1.412.963.6649 or via e-mail to info@neuro-kinetics.com.

ABOUT NEURO KINETICS INC.

Neuro Kinetics Inc. (www.neuro-kinetics.com) is a fast-growing manufacturer of noninvasive medical test equipment used worldwide by audiologists, neurologists, neuro-otologists, ophthalmologists, otolaryngologists and other medical specialists in the detection and evaluation of neurological, otological and vestibular disorders. The privately owned company, founded in the 1970s, pioneered the development of vestibular and neuro-otologic testing equipment, including the renowned Barany (rotational) chair. The company's products include the I-Portal(R) NOTC System (Neuro-Otologic Test Center), I-Portal(R) VNG (Video Nystagmography) system and I-Portal(R) VOG (Video-Oculography) system, along with related accessories, software, training and support services. Users include doctors and researchers in universities and government facilities as well as specialists in fields such as audiology, neurology, neuro-otology, ophthalmology and otolaryngology.

    MEDIA CONTACT

    John Buckman
    Buckman Communications, for Neuro Kinetics, Inc.
    + 1 412-381-2900 or jbuckman@buckman.biz


'/>"/>
SOURCE Neuro Kinetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
2. New research shows how chronic stress worsens neurodegenerative disease course
3. NYU study points to lasting impact of mild hearing loss on neurological processes
4. Low level of neuronal receptor linked to mild cognitive impairment and Alzheimers disease
5. Special Conference: Women and Neurological Diseases
6. Neurobiological Technologies Reports Going Concern Qualification
7. Brandeis neuroscientist wins NIH directors Pioneer Award
8. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
9. Kids Vaccine Ingredient Not Likely Linked to Neurological Problems
10. Loss of gene leads to protein splicing and buildup of toxic proteins in neurons
11. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... human performance, is proud to announce that it has received 510(k) clearance from ... the MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling ...
(Date:4/25/2017)... (PRWEB) , ... April 25, ... ... based in Newport Beach, California, committed to raising awareness for Duchenne muscular ... results from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial ...
(Date:4/25/2017)... BC (PRWEB) , ... April 25, 2017 , ... The ... from Richmond, BC, who live with dental fear and require sedation to receive dental ... at ease during various procedures, from hygienic cleanings to oral surgery, at their ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as well ... society for this important science. , The Teratology Society is ...
(Date:4/25/2017)... Clara, CA (PRWEB) , ... April 25, 2017 ... ... announces the addition of predictive analytics to its patient care management module. Using ... compliance even before a patient has been initiated on continuous positive airway pressure ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
Breaking Medicine Technology: